Pyrethroid [EPC]

Pyrethroid [EPC] was reported 1762 times

Drugs of the Pyrethroid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 KORSAKOFF'S PSYCHOSIS ALCOHOLIC 1 0.2500
1 CHEMICAL ABUSER 1 0.2000
2 LICE INFESTATION 14 0.0667
3 VENTOUSE EXTRACTION 2 0.0541
4 BILIARY ADENOMA 1 0.0500
5 HCOV-HKU1 INFECTION 1 0.0476
6 SCABIES 7 0.0409
7 DELUSION OF PARASITOSIS 6 0.0382
8 OVARIAN ADHESION 3 0.0375
9 APPLICATION SITE DESQUAMATION 1 0.0345
10 PREGNANCY WITH INJECTABLE CONTRACEPTIVE 7 0.0329
11 ACARODERMATITIS 33 0.0302
12 GASTRIC DYSPLASIA 1 0.0213
13 BENIGN NEOPLASM OF EYE 1 0.0200
14 APPLICATION SITE ABSCESS 1 0.0172
15 CAROTIDYNIA 1 0.0172
16 BLOOD TRIGLYCERIDES 1 0.0128
17 PELVIC ADHESIONS 3 0.0126
18 IDIOPATHIC GENERALISED EPILEPSY 1 0.0118
19 CARDIOACTIVE DRUG LEVEL DECREASED 2 0.0118
20 COLON GANGRENE 1 0.0108
21 HERPES SIMPLEX TEST POSITIVE 2 0.0101
22 SALPINGITIS 3 0.0094
23 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
24 HYPERPHOSPHATURIA 1 0.0085
25 APPLICATION SITE HYPOAESTHESIA 2 0.0085
26 MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0082
27 LARYNGEAL NEOPLASM 1 0.0082
28 FEMOROACETABULAR IMPINGEMENT 1 0.0081
29 INFESTATION 2 0.0077
30 BRIEF RESOLVED UNEXPLAINED EVENT 1 0.0076
31 EXPLORATIVE LAPAROTOMY 1 0.0072
32 AUTOMATIC BLADDER 1 0.0072
33 EYE REDNESS 2 0.0071
34 ADNEXA UTERI MASS 2 0.0069
35 APPLICATION SITE ODOUR 1 0.0069
36 HAIR GROWTH RATE ABNORMAL 1 0.0068
37 CATARACT CORTICAL 1 0.0067
38 ANAL HAEMORRHAGE 18 0.0064
39 CAUSTIC INJURY 2 0.0064
40 RETROPERITONEAL LYMPHADENOPATHY 3 0.0057
41 EYELASH CHANGES 1 0.0056
42 APPLICATION SITE PUSTULES 2 0.0055
43 EJACULATION FAILURE 11 0.0055
44 BORDERLINE GLAUCOMA 1 0.0054
45 DEHISCENCE 1 0.0053
46 GENERAL PHYSICAL CONDITION DECREASED 1 0.0053
47 CHEMICAL BURN 6 0.0052
48 GENITAL INFECTION FEMALE 1 0.0052
49 SCAR PAIN 2 0.0050
50 EXPOSURE TO FUNGUS 1 0.0047
51 HIP DYSPLASIA 1 0.0045
52 COLORECTAL ADENOCARCINOMA 1 0.0045
53 PERINEAL ABSCESS 2 0.0044
54 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
55 INFANTILE APNOEIC ATTACK 1 0.0043
56 EAR NEOPLASM MALIGNANT 1 0.0042
57 HELMINTHIC INFECTION 1 0.0041
58 BREAST DISORDER FEMALE 1 0.0039
59 CORNEAL THINNING 1 0.0039
60 SALIVARY GLAND ENLARGEMENT 2 0.0038
61 APPLICATION SITE PAPULES 4 0.0038
62 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
63 RETICULOCYTE COUNT INCREASED 3 0.0037
64 MOLLUSCUM CONTAGIOSUM 2 0.0037
65 CUTIS LAXA 1 0.0037
66 INFECTED BITES 1 0.0037
67 APPLICATION SITE MASS 1 0.0036
68 CHEMICAL BURNS OF EYE 1 0.0036
69 ANDROGENETIC ALOPECIA 1 0.0035
70 BURNS FIRST DEGREE 1 0.0035
71 HAIR INJURY 1 0.0034
72 CONGENITAL CHOROID PLEXUS CYST 1 0.0033
73 TALIPES 10 0.0032
74 BENIGN INTRACRANIAL HYPERTENSION 4 0.0032
75 APPLICATION SITE PARAESTHESIA 4 0.0031
76 HEPATITIS C RNA INCREASED 1 0.0029
77 CUTANEOUS SYMPTOM 2 0.0029
78 ASTHMA EXERCISE INDUCED 1 0.0029
79 INFECTED DERMAL CYST 1 0.0028
80 CHEMICAL BURN OF SKIN 7 0.0028
81 OTITIS MEDIA ACUTE 2 0.0027
82 PERIRECTAL ABSCESS 3 0.0027
83 EXPOSURE TO COMMUNICABLE DISEASE 2 0.0027
84 INFECTION PARASITIC 2 0.0026
85 ARACHNOID CYST 1 0.0025
86 HIDRADENITIS 23 0.0025
87 ENDOMETRIAL HYPERTROPHY 1 0.0025
88 CHEMICAL INJURY 2 0.0024
89 HYPERPARATHYROIDISM SECONDARY 6 0.0024
90 EXPOSURE VIA EYE CONTACT 1 0.0024
91 SKIN WOUND 4 0.0024
92 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 2 0.0023
93 ALLERGY TO PLANTS 1 0.0022
94 RHINALGIA 6 0.0022
95 INCISION SITE ERYTHEMA 1 0.0022
96 ECZEMA HERPETICUM 1 0.0022
97 VENOUS INJURY 2 0.0021
98 BIOPSY BONE MARROW 1 0.0021
99 BUNDLE BRANCH BLOCK 2 0.0021
100 AIR EMBOLISM 1 0.0021
101 JAUNDICE NEONATAL 4 0.0021
102 PARTNER STRESS 2 0.0021
103 REBOUND ACID HYPERSECRETION 6 0.0020
104 ANIMAL BITE 5 0.0019
105 FRACTURE PAIN 1 0.0019
106 COSTOCHONDRITIS 3 0.0018
107 HAEMORRHAGIC INFARCTION 1 0.0018
108 DANDRUFF 4 0.0018
109 TRICHORRHEXIS 5 0.0018
110 RHEUMATOID FACTOR INCREASED 2 0.0018
111 BODY TINEA 1 0.0018
112 NEPHROGENIC ANAEMIA 8 0.0017
113 RECTAL ULCER 2 0.0017
114 HYPOAESTHESIA EYE 1 0.0017
115 ENDOSCOPY 1 0.0017
116 AURICULAR SWELLING 1 0.0017
117 SPONDYLITIS 6 0.0016
118 TOOTH EROSION 2 0.0016
119 XEROSIS 2 0.0016
120 DIAPHRAGMATIC HERNIA 1 0.0016
121 PRODUCT USED FOR UNKNOWN INDICATION 2 0.0016
122 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
123 INTERNAL INJURY 1 0.0015
124 ECONOMIC PROBLEM 23 0.0015
125 SCRATCH 16 0.0015
126 CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0015
127 HALLUCINATION, TACTILE 1 0.0015
128 CHOLECYSTITIS CHRONIC 10 0.0015
129 ANHEDONIA 39 0.0015
130 CHOREOATHETOSIS 1 0.0015
131 PRODUCT PHYSICAL CONSISTENCY ISSUE 8 0.0014
132 CRANIAL NERVE DISORDER 1 0.0014
133 PAPULE 10 0.0014
134 APPLICATION SITE SCAB 3 0.0014
135 NASAL DISCOMFORT 11 0.0014
136 PYELONEPHRITIS 12 0.0014
137 BITE 1 0.0014
138 FIBROCYSTIC BREAST DISEASE 1 0.0014
139 TEMPERATURE REGULATION DISORDER 3 0.0013
140 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
141 COMPLICATION OF PREGNANCY 1 0.0013
142 EYELID FUNCTION DISORDER 1 0.0013
143 SKIN INFECTION 14 0.0012
144 BRONCHOPULMONARY DYSPLASIA 1 0.0012
145 ENDOMETRIAL HYPERPLASIA 1 0.0012
146 COMPULSIVE SEXUAL BEHAVIOUR 1 0.0012
147 SKIN HAEMORRHAGE 18 0.0012
148 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
149 APPLICATION SITE SWELLING 6 0.0012
150 HAIR TEXTURE ABNORMAL 16 0.0012
151 APPLICATION SITE PAIN 26 0.0012
152 SEIZURE LIKE PHENOMENA 2 0.0012
153 GENITAL BURNING SENSATION 1 0.0012
154 ENDOCRINE OPHTHALMOPATHY 1 0.0012
155 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
156 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
157 ACUTE CHEST SYNDROME 1 0.0011
158 INFUSION SITE DISCOLOURATION 1 0.0011
159 DRUG DETOXIFICATION 1 0.0011
160 SKIN DISCOMFORT 3 0.0011
161 CERUMEN IMPACTION 1 0.0011
162 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
163 ADENOCARCINOMA GASTRIC 1 0.0011
164 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 19 0.0010
165 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
166 INCORRECT PRODUCT ADMINISTRATION DURATION 22 0.0010
167 APPLICATION SITE BURN 5 0.0010
168 FORMICATION 7 0.0010
169 REBOUND ATOPIC DERMATITIS 2 0.0010
170 AUTONOMIC NEUROPATHY 1 0.0010
171 BREAST ABSCESS 1 0.0010
172 DEMYELINATING POLYNEUROPATHY 1 0.0010
173 APPLICATION SITE EXFOLIATION 4 0.0010
174 JOINT SPRAIN 1 0.0010
175 DILATATION VENTRICULAR 2 0.0010
176 HYPOPERFUSION 1 0.0010
177 ABDOMINAL ADHESIONS 3 0.0009
178 BONE DEMINERALISATION 1 0.0009
179 EAR SWELLING 2 0.0009
180 APPLICATION SITE PRURITUS 21 0.0009
181 OSTEOPENIA 14 0.0009
182 COLONOSCOPY 2 0.0009
183 APPLICATION SITE DRYNESS 3 0.0009
184 CHRONIC KIDNEY DISEASE 67 0.0009
185 CEREBRAL VENTRICLE DILATATION 1 0.0009
186 LYMPHOEDEMA 6 0.0009
187 APPLICATION SITE DISCHARGE 1 0.0009
188 REACTION TO EXCIPIENT 2 0.0009
189 GROIN ABSCESS 1 0.0008
190 PREMATURE RUPTURE OF MEMBRANES 2 0.0008
191 RASH VESICULAR 4 0.0008
192 DERMATITIS ACNEIFORM 5 0.0008
193 GASTROINTESTINAL TUBE INSERTION 2 0.0008
194 FISTULA DISCHARGE 1 0.0008
195 SCAB 9 0.0008
196 EXCORIATION 2 0.0008
197 COMMUNICATION DISORDER 3 0.0008
198 ENDOCRINE DISORDER 1 0.0008
199 HEPATOSPLENOMEGALY 2 0.0008
200 APPLICATION SITE EROSION 1 0.0008
201 LIPOMA 2 0.0008
202 ACTINIC KERATOSIS 2 0.0008
203 PROCEDURAL HAEMORRHAGE 3 0.0008
204 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
205 ACROCHORDON 1 0.0008
206 APPLICATION SITE DISCOLOURATION 3 0.0007
207 APPLICATION SITE INFLAMMATION 1 0.0007
208 DISCHARGE 1 0.0007
209 INCISIONAL HERNIA 1 0.0007
210 END STAGE RENAL DISEASE 13 0.0007
211 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
212 AORTIC VALVE INCOMPETENCE 3 0.0007
213 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
214 PSORIATIC ARTHROPATHY 28 0.0007
215 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 49 0.0007
216 BILIARY COLIC 2 0.0007
217 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
218 GENITAL PAIN 1 0.0007
219 EXCESSIVE EYE BLINKING 1 0.0007
220 HYPOPHOSPHATAEMIA 5 0.0007
221 CONJUNCTIVITIS ALLERGIC 1 0.0007
222 ARTHROPOD BITE 5 0.0007
223 AXILLARY PAIN 1 0.0007
224 EMBOLISM VENOUS 2 0.0007
225 DYSPAREUNIA 3 0.0007
226 CALCULUS URINARY 1 0.0006
227 DECREASED ACTIVITY 7 0.0006
228 INCORRECT DRUG ADMINISTRATION DURATION 18 0.0006
229 BONE DENSITY DECREASED 20 0.0006
230 SKIN ABRASION 3 0.0006
231 SKIN IRRITATION 29 0.0006
232 HISTOPLASMOSIS DISSEMINATED 1 0.0006
233 SKIN DISORDER 21 0.0006
234 NERVE INJURY 7 0.0006
235 TRICUSPID VALVE INCOMPETENCE 5 0.0006
236 EXPOSURE TO TOXIC AGENT 2 0.0006
237 VENTRICULAR HYPOKINESIA 2 0.0006
238 SKIN EROSION 2 0.0006
239 DRUG EXPOSURE DURING PREGNANCY 21 0.0006
240 DEAFNESS NEUROSENSORY 2 0.0006
241 SKIN INJURY 2 0.0006
242 SKIN PLAQUE 5 0.0006
243 BILIARY DYSKINESIA 1 0.0006
244 APPLICATION SITE RASH 8 0.0006
245 FIXED ERUPTION 1 0.0006
246 ACUTE SINUSITIS 1 0.0006
247 KIDNEY FIBROSIS 1 0.0006
248 DERMATITIS EXFOLIATIVE GENERALISED 2 0.0006
249 FOLLICULITIS 6 0.0006
250 NECROTISING FASCIITIS 2 0.0006
251 FOOD INTERACTION 1 0.0006
252 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
253 APPLICATION SITE IRRITATION 7 0.0006
254 JUGULAR VEIN THROMBOSIS 1 0.0006
255 SKIN WEEPING 2 0.0006
256 APPLICATION SITE DISCOMFORT 1 0.0006
257 PYODERMA GANGRENOSUM 2 0.0006
258 DERMATITIS BULLOUS 4 0.0006
259 BONE DISORDER 10 0.0005
260 NONSPECIFIC REACTION 3 0.0005
261 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 30 0.0005
262 ESSENTIAL HYPERTENSION 1 0.0005
263 BODY TEMPERATURE ABNORMAL 1 0.0005
264 DRY SKIN 72 0.0005
265 PULMONARY MASS 8 0.0005
266 AURA 1 0.0005
267 HYPERTENSIVE HEART DISEASE 1 0.0005
268 IMPATIENCE 1 0.0005
269 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 9 0.0005
270 BURNING SENSATION 37 0.0005
271 GUN SHOT WOUND 1 0.0005
272 FACE INJURY 2 0.0005
273 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
274 ADRENAL DISORDER 1 0.0005
275 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
276 CONGENITAL ANOMALY 4 0.0005
277 ATROPHY 1 0.0005
278 GALLBLADDER INJURY 1 0.0005
279 HYPERTRIGLYCERIDAEMIA 3 0.0005
280 JOINT NOISE 1 0.0005
281 SKIN ODOUR ABNORMAL 2 0.0005
282 BODY TEMPERATURE DECREASED 5 0.0005
283 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
284 SKIN ULCER 13 0.0005
285 HYPERPHAGIA 2 0.0005
286 APPLICATION SITE ERYTHEMA 13 0.0005
287 FOETAL GROWTH RESTRICTION 3 0.0005
288 SPINAL FUSION SURGERY 2 0.0005
289 COMPULSIVE SHOPPING 1 0.0005
290 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
291 BODY TEMPERATURE FLUCTUATION 1 0.0005
292 BUNDLE BRANCH BLOCK LEFT 2 0.0005
293 FOETAL DISTRESS SYNDROME 1 0.0005
294 MELANOCYTIC NAEVUS 2 0.0005
295 ONYCHOMYCOSIS 2 0.0005
296 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
297 CATHETERISATION CARDIAC 2 0.0005
298 RHINITIS ALLERGIC 2 0.0004
299 QUALITY OF LIFE DECREASED 6 0.0004
300 APPLICATION SITE URTICARIA 1 0.0004
301 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
302 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
303 HAIR GROWTH ABNORMAL 3 0.0004
304 SKIN BURNING SENSATION 31 0.0004
305 NEPHROPATHY 4 0.0004
306 SKIN TIGHTNESS 2 0.0004
307 HAND FRACTURE 3 0.0004
308 INGROWING NAIL 1 0.0004
309 SUBCUTANEOUS ABSCESS 2 0.0004
310 DERMAL CYST 1 0.0004
311 CARTILAGE INJURY 1 0.0004
312 MOVEMENT DISORDER 13 0.0004
313 INFLAMMATORY MARKER INCREASED 2 0.0004
314 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
315 EYE IRRITATION 23 0.0004
316 BONE LOSS 6 0.0004
317 CELLULITIS 20 0.0004
318 EMOTIONAL DISTRESS 48 0.0004
319 VULVOVAGINAL PRURITUS 2 0.0004
320 DIABETIC COMPLICATION 1 0.0004
321 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
322 EXPIRED PRODUCT ADMINISTERED 13 0.0004
323 CEREBRAL ISCHAEMIA 2 0.0004
324 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
325 FAILURE TO THRIVE 2 0.0004
326 PERIORBITAL OEDEMA 2 0.0004
327 HYPERSENSITIVITY VASCULITIS 1 0.0004
328 OBESITY 6 0.0004
329 LEARNING DISABILITY 2 0.0004
330 PRURITUS 144 0.0004
331 ABDOMINAL MASS 1 0.0004
332 PRODUCT RESIDUE PRESENT 2 0.0004
333 BLOOD SODIUM INCREASED 1 0.0004
334 GAMBLING DISORDER 1 0.0004
335 SKIN LESION 10 0.0004
336 HAIR DISORDER 3 0.0004
337 PHOTOSENSITIVITY REACTION 6 0.0004
338 DRUG SCREEN FALSE POSITIVE 1 0.0004
339 LIVE BIRTH 3 0.0004
340 ATRIAL SEPTAL DEFECT 3 0.0004
341 ANTIPSYCHOTIC DRUG LEVEL INCREASED 1 0.0004
342 PREMATURE LABOUR 2 0.0004
343 ALOPECIA 69 0.0004
344 SCAR 6 0.0004
345 IMPAIRED QUALITY OF LIFE 5 0.0003
346 FIBULA FRACTURE 1 0.0003
347 SKIN SWELLING 3 0.0003
348 SPINAL OSTEOARTHRITIS 3 0.0003
349 TUMOUR LYSIS SYNDROME 3 0.0003
350 RENAL FAILURE 45 0.0003
351 RENAL INJURY 10 0.0003
352 PAIN OF SKIN 9 0.0003
353 HIV INFECTION 1 0.0003
354 VULVOVAGINAL BURNING SENSATION 2 0.0003
355 UROSEPSIS 3 0.0003
356 PRURITUS GENERALISED 7 0.0003
357 ANKLE FRACTURE 5 0.0003
358 SCOLIOSIS 2 0.0003
359 HAIR COLOUR CHANGES 4 0.0003
360 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
361 SWELLING OF EYELID 2 0.0003
362 MULTIPLE INJURIES 2 0.0003
363 DRUG EFFECT INCREASED 1 0.0003
364 BLADDER PAIN 1 0.0003
365 SCREAMING 2 0.0003
366 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
367 APPLICATION SITE VESICLES 2 0.0003
368 BACK DISORDER 5 0.0003
369 FACET JOINT SYNDROME 1 0.0003
370 PHARYNGEAL SWELLING 3 0.0003
371 HEPATIC NEOPLASM 1 0.0003
372 LIP SWELLING 10 0.0003
373 ANXIETY DISORDER 1 0.0003
374 JOINT RANGE OF MOTION DECREASED 4 0.0003
375 PRODUCT LABEL ISSUE 2 0.0003
376 TOOTH ABSCESS 3 0.0003
377 HEPATIC CYST 1 0.0003
378 B-CELL LYMPHOMA 1 0.0003
379 DIABETIC RETINOPATHY 1 0.0003
380 DRUG TOXICITY 4 0.0003
381 OSTEOPOROSIS 12 0.0003
382 PSORIASIS 38 0.0003
383 DIFFICULTY IN WALKING 1 0.0003
384 TOOTH LOSS 6 0.0003
385 EYE DISCHARGE 3 0.0003
386 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
387 TENDERNESS 3 0.0003
388 MASS 4 0.0003
389 CARPAL TUNNEL SYNDROME 4 0.0003
390 APPLICATION SITE REACTION 2 0.0003
391 HANGOVER 1 0.0003
392 HEART DISEASE CONGENITAL 1 0.0003
393 DIVERTICULUM 2 0.0003
394 HAEMORRHAGIC DIATHESIS 1 0.0003
395 SUBDURAL HAEMATOMA 4 0.0003
396 FRUSTRATION 1 0.0003
397 GASTROINTESTINAL DISORDER 25 0.0003
398 BONE LESION 1 0.0003
399 DRUG INEFFECTIVE 365 0.0003
400 DEVICE KINK 1 0.0003
401 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
402 ASTHMATIC CRISIS 1 0.0003
403 HYPOMANIA 1 0.0003
404 DENTAL CARIES 3 0.0003
405 CARDIOMYOPATHY 4 0.0003
406 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
407 CONJUNCTIVITIS 5 0.0003
408 HYPERACUSIS 1 0.0003
409 RASH PAPULAR 6 0.0003
410 JOINT STIFFNESS 7 0.0003
411 REBOUND EFFECT 3 0.0003
412 MITRAL VALVE INCOMPETENCE 3 0.0003
413 DERMATITIS CONTACT 3 0.0003
414 TROPONIN INCREASED 2 0.0003
415 CHOLECYSTECTOMY 3 0.0003
416 SKIN EXFOLIATION 22 0.0003
417 FOOD ALLERGY 2 0.0003
418 EPIGASTRIC DISCOMFORT 1 0.0003
419 MULTIPLE ALLERGIES 2 0.0003
420 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
421 DRUG SCREEN POSITIVE 2 0.0003
422 PRODUCT PRESCRIBING ERROR 6 0.0003
423 EXPOSURE VIA BREAST MILK 1 0.0003
424 HYPERLIPIDAEMIA 3 0.0003
425 RASH ERYTHEMATOUS 12 0.0003
426 CEREBRAL ATROPHY 1 0.0003
427 BLOOD DISORDER 2 0.0002
428 BLEPHARITIS 1 0.0002
429 SENSORY DISTURBANCE 4 0.0002
430 FUNGAL SKIN INFECTION 1 0.0002
431 MYASTHENIA GRAVIS 2 0.0002
432 BURSITIS 3 0.0002
433 GALLBLADDER OPERATION 1 0.0002
434 ANXIETY 70 0.0002
435 GOITRE 1 0.0002
436 MULTIPLE FRACTURES 4 0.0002
437 GENERALISED OEDEMA 3 0.0002
438 ACCIDENTAL EXPOSURE 1 0.0002
439 INJECTION SITE DISCOLOURATION 3 0.0002
440 RASH PRURITIC 13 0.0002
441 ERYTHEMA 49 0.0002
442 DRUG USE DISORDER 2 0.0002
443 OSTEOARTHRITIS 10 0.0002
444 ACUTE KIDNEY INJURY 36 0.0002
445 DEVICE DEPLOYMENT ISSUE 3 0.0002
446 ABSCESS LIMB 1 0.0002
447 HEPATIC PAIN 1 0.0002
448 ALCOHOLISM 1 0.0002
449 DRUG RESISTANCE 6 0.0002
450 ABNORMAL SENSATION IN EYE 1 0.0002
451 CARDIAC MURMUR 2 0.0002
452 HORDEOLUM 1 0.0002
453 TREATMENT FAILURE 19 0.0002
454 NEUROTOXICITY 4 0.0002
455 DERMATITIS ATOPIC 12 0.0002
456 PULMONARY CONGESTION 3 0.0002
457 GRIP STRENGTH DECREASED 2 0.0002
458 BLOOD CREATINE INCREASED 1 0.0002
459 EAR DISORDER 1 0.0002
460 RETINAL DETACHMENT 2 0.0002
461 PROCEDURAL PAIN 6 0.0002
462 PARAESTHESIA 34 0.0002
463 ERYTHEMA MULTIFORME 2 0.0002
464 CHOLELITHIASIS 7 0.0002
465 FLANK PAIN 2 0.0002
466 SKIN REACTION 3 0.0002
467 SQUAMOUS CELL CARCINOMA 2 0.0002
468 HYPOCALCAEMIA 4 0.0002
469 SUICIDAL IDEATION 19 0.0002
470 HYPERCHOLESTEROLAEMIA 2 0.0002
471 GUILLAIN-BARRE SYNDROME 1 0.0002
472 PRESCRIBED OVERDOSE 4 0.0002
473 PRODUCT USE IN UNAPPROVED INDICATION 51 0.0002
474 VITAMIN D DEFICIENCY 2 0.0002
475 SKIN FISSURES 4 0.0002
476 RENAL TUBULAR NECROSIS 2 0.0002
477 DIABETIC NEUROPATHY 1 0.0002
478 ABDOMINAL TENDERNESS 1 0.0002
479 OVARIAN CYST 2 0.0002
480 DERMATITIS EXFOLIATIVE 1 0.0002
481 SWELLING FACE 13 0.0002
482 CORONARY ARTERY STENOSIS 1 0.0002
483 DYSPHORIA 1 0.0002
484 HYPOTHERMIA 2 0.0002
485 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40 0.0002
486 MOTOR DYSFUNCTION 2 0.0002
487 BODY TEMPERATURE INCREASED 4 0.0002
488 HIP ARTHROPLASTY 3 0.0002
489 BLISTER 11 0.0002
490 SKIN DISCOLOURATION 9 0.0002
491 NEUTROPHIL COUNT INCREASED 2 0.0002
492 EAR DISCOMFORT 2 0.0002
493 MUSCULOSKELETAL CHEST PAIN 3 0.0002
494 TEMPERATURE INTOLERANCE 2 0.0002
495 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
496 RASH GENERALISED 5 0.0002
497 CONVULSION 11 0.0002
498 THERAPY PARTIAL RESPONDER 3 0.0002
499 BASAL CELL CARCINOMA 3 0.0002
500 PETECHIAE 2 0.0002
501 DERMATITIS 4 0.0002
502 ARTHRITIS 15 0.0002
503 CATATONIA 1 0.0002
504 DRUG ADMINISTERED AT INAPPROPRIATE SITE 2 0.0002
505 RESPIRATORY TRACT CONGESTION 3 0.0002
506 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
507 HYPERSENSITIVITY 35 0.0002
508 RASH 82 0.0002
509 IMPAIRED WORK ABILITY 4 0.0002
510 BODY HEIGHT DECREASED 2 0.0002
511 FEAR 5 0.0002
512 ANAL ABSCESS 1 0.0002
513 BEHAVIOUR DISORDER 1 0.0002
514 THROAT TIGHTNESS 5 0.0002
515 ACCIDENTAL EXPOSURE TO PRODUCT 19 0.0002
516 SKIN LACERATION 2 0.0002
517 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
518 PULMONARY THROMBOSIS 2 0.0002
519 OSTEONECROSIS 6 0.0002
520 INJECTION SITE NODULE 2 0.0002
521 DEAFNESS UNILATERAL 1 0.0002
522 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
523 FEELING COLD 5 0.0002
524 NECK PAIN 10 0.0002
525 CHOLECYSTITIS ACUTE 1 0.0002
526 GRANULOCYTOPENIA 1 0.0002
527 CARDIAC VALVE DISEASE 1 0.0002
528 HYPERTONIA 1 0.0002
529 THROMBOSIS 14 0.0002
530 EXERCISE TOLERANCE DECREASED 1 0.0002
531 NIGHTMARE 6 0.0002
532 HYPERVENTILATION 1 0.0002
533 ECZEMA 9 0.0002
534 DECREASED INTEREST 1 0.0002
535 HEAD DISCOMFORT 3 0.0002
536 DRUG ERUPTION 3 0.0002
537 VISION BLURRED 23 0.0002
538 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
539 PELVIC PAIN 3 0.0002
540 CORONARY ARTERY DISEASE 5 0.0002
541 SCHIZOPHRENIA 2 0.0002
542 NEURALGIA 4 0.0002
543 INGUINAL HERNIA 1 0.0002
544 NO THERAPEUTIC RESPONSE 2 0.0002
545 DISCOMFORT 10 0.0002
546 EPISTAXIS 12 0.0002
547 FOOT FRACTURE 3 0.0002
548 LIVER DISORDER 7 0.0002
549 INJECTION SITE IRRITATION 2 0.0002
550 HYPOTHYROIDISM 5 0.0002
551 DRUG PRESCRIBING ERROR 3 0.0002
552 THERAPY NON-RESPONDER 7 0.0002
553 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
554 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
555 BREAST CANCER STAGE III 1 0.0002
556 ANGINA UNSTABLE 1 0.0002
557 PAIN 94 0.0002
558 TOOTH INFECTION 2 0.0002
559 DEPRESSED MOOD 8 0.0002
560 HAEMATOCRIT DECREASED 3 0.0002
561 COMPLICATION OF DEVICE INSERTION 3 0.0002
562 BLOOD CHOLESTEROL INCREASED 7 0.0002
563 EYE HAEMORRHAGE 2 0.0001
564 GAIT INABILITY 5 0.0001
565 CYTOKINE RELEASE SYNDROME 3 0.0001
566 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
567 MALIGNANT MELANOMA 2 0.0001
568 BRONCHITIS 11 0.0001
569 INTENTIONAL PRODUCT MISUSE 13 0.0001
570 VERTIGO 9 0.0001
571 IMPAIRED GASTRIC EMPTYING 2 0.0001
572 ABNORMAL LOSS OF WEIGHT 1 0.0001
573 BLOOD TESTOSTERONE DECREASED 1 0.0001
574 CORONARY ARTERY OCCLUSION 2 0.0001
575 ANAPHYLACTIC REACTION 8 0.0001
576 DROOLING 1 0.0001
577 URTICARIA 24 0.0001
578 EXTRASYSTOLES 1 0.0001
579 DEFAECATION URGENCY 1 0.0001
580 LYMPHADENOPATHY 5 0.0001
581 EATING DISORDER 3 0.0001
582 SINUS TACHYCARDIA 2 0.0001
583 PARALYSIS 2 0.0001
584 RECTAL HAEMORRHAGE 6 0.0001
585 GRAFT VERSUS HOST DISEASE 1 0.0001
586 VAGINAL HAEMORRHAGE 6 0.0001
587 MENTAL DISORDER 6 0.0001
588 CRYING 5 0.0001
589 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
590 MUSCULOSKELETAL STIFFNESS 12 0.0001
591 GASTROOESOPHAGEAL REFLUX DISEASE 11 0.0001
592 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
593 NASAL CONGESTION 8 0.0001
594 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
595 CEREBRAL DISORDER 1 0.0001
596 MATERNAL EXPOSURE DURING PREGNANCY 12 0.0001
597 PREMATURE BABY 4 0.0001
598 HYPOAESTHESIA ORAL 2 0.0001
599 INTESTINAL OBSTRUCTION 5 0.0001
600 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
601 DRUG ADMINISTRATION ERROR 4 0.0001
602 MUSCLE TWITCHING 3 0.0001
603 PHARYNGEAL OEDEMA 2 0.0001
604 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
605 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
606 EJECTION FRACTION DECREASED 2 0.0001
607 OFF LABEL USE 112 0.0001
608 AFFECTIVE DISORDER 1 0.0001
609 SICKLE CELL ANAEMIA WITH CRISIS 2 0.0001
610 FURUNCLE 1 0.0001
611 HALLUCINATION, AUDITORY 2 0.0001
612 ABSCESS 2 0.0001
613 ABDOMINAL DISCOMFORT 21 0.0001
614 CONDITION AGGRAVATED 38 0.0001
615 RHINORRHOEA 8 0.0001
616 FIBROMYALGIA 3 0.0001
617 URINARY TRACT INFECTION 21 0.0001
618 HEADACHE 77 0.0001
619 DECUBITUS ULCER 1 0.0001
620 IMPAIRED HEALING 4 0.0001
621 HYPERAESTHESIA 1 0.0001
622 STAPHYLOCOCCAL INFECTION 4 0.0001
623 SEIZURE 14 0.0001
624 FEELING ABNORMAL 29 0.0001
625 EXTRAPYRAMIDAL DISORDER 3 0.0001
626 HYPOAESTHESIA 18 0.0001
627 HEMIPLEGIA 1 0.0001
628 RENAL IMPAIRMENT 10 0.0001
629 TYPE 2 DIABETES MELLITUS 4 0.0001
630 FACE OEDEMA 2 0.0001
631 BACK PAIN 27 0.0001
632 MIGRAINE 11 0.0001
633 MUSCULOSKELETAL PAIN 6 0.0001
634 RASH MACULAR 4 0.0001
635 DEPRESSION 26 0.0001
636 EOSINOPHILIA 2 0.0001
637 BLOOD CALCIUM INCREASED 1 0.0001
638 GASTRITIS 3 0.0001
639 GROIN PAIN 1 0.0001
640 SLEEP DISORDER 8 0.0001
641 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
642 ISCHAEMIC STROKE 2 0.0001
643 FACIAL PAIN 1 0.0001
644 JAUNDICE 3 0.0001
645 ANAL INCONTINENCE 1 0.0001
646 DEVELOPMENTAL DELAY 1 0.0001
647 EXOSTOSIS 1 0.0001
648 DYSURIA 4 0.0001
649 IRON DEFICIENCY ANAEMIA 1 0.0001
650 GRAND MAL CONVULSION 1 0.0001
651 MEDICATION ERROR 6 0.0001
652 JOINT SWELLING 13 0.0001
653 EYE SWELLING 4 0.0001
654 HEPATIC STEATOSIS 2 0.0001
655 WOUND 3 0.0001
656 RENAL DISORDER 5 0.0001
657 DEFORMITY 1 0.0001
658 DIARRHOEA HAEMORRHAGIC 1 0.0001
659 OEDEMA PERIPHERAL 13 0.0001
660 OVERDOSE 23 0.0001
661 ARTERIOSCLEROSIS 1 0.0001
662 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
663 UNEVALUABLE EVENT 8 0.0001
664 OCULAR HYPERAEMIA 5 0.0001
665 DISEASE RECURRENCE 5 0.0001
666 SLEEP APNOEA SYNDROME 2 0.0001
667 ANGINA PECTORIS 3 0.0001
668 CONTUSION 10 0.0001
669 INFECTION 15 0.0001
670 ERUCTATION 2 0.0001
671 EAR PAIN 2 0.0001
672 DYSSTASIA 3 0.0001
673 AUTOIMMUNE DISORDER 1 0.0001
674 HAEMORRHOIDS 2 0.0001
675 TREMOR 17 0.0001
676 MENORRHAGIA 2 0.0001
677 PAIN IN EXTREMITY 30 0.0001
678 KNEE OPERATION 1 0.0001
679 HOSPICE CARE 1 0.0001
680 DISABILITY 2 0.0001
681 ABNORMAL BEHAVIOUR 4 0.0001
682 HEART RATE INCREASED 10 0.0001
683 BLADDER DISORDER 1 0.0001
684 INABILITY TO AFFORD MEDICATION 1 0.0001
685 UPPER LIMB FRACTURE 2 0.0001
686 MYALGIA 17 0.0001
687 BRAIN INJURY 1 0.0001
688 PRODUCT PHYSICAL ISSUE 2 0.0001
689 THERAPEUTIC RESPONSE DECREASED 6 0.0001
690 FEEDING DISORDER 2 0.0001
691 DYSKINESIA 4 0.0001
692 EYELID PTOSIS 1 0.0001
693 DRY THROAT 1 0.0001
694 SINUSITIS 10 0.0001
695 INITIAL INSOMNIA 1 0.0001
696 EMOTIONAL DISORDER 3 0.0001
697 NAUSEA 77 0.0001
698 ILLNESS 10 0.0001
699 SWELLING 9 0.0001
700 INTENTIONAL DRUG MISUSE 2 0.0001
701 SPEECH DISORDER 5 0.0001
702 INJECTION SITE DISCOMFORT 1 0.0001
703 MOUTH ULCERATION 2 0.0001
704 CYSTITIS 3 0.0001
705 VOMITING 44 0.0001
706 SKIN CANCER 2 0.0001
707 HALLUCINATION 7 0.0001
708 FAECES DISCOLOURED 2 0.0001
709 PRODUCT DOSE OMISSION 6 0.0001
710 PRODUCT PRESCRIBING ISSUE 2 0.0001
711 DYSPEPSIA 9 0.0001
712 EYE DISORDER 3 0.0001
713 GASTROINTESTINAL PAIN 1 0.0001
714 DIZZINESS 45 0.0001
715 FOOT DEFORMITY 1 0.0001
716 TOOTH DISORDER 2 0.0001
717 RASH MACULO-PAPULAR 2 0.0001
718 ORAL PAIN 2 0.0001
719 EYE PRURITUS 3 0.0001
720 THROAT IRRITATION 4 0.0001
721 ANGER 3 0.0001
722 EYE PAIN 5 0.0001
723 EYE INFECTION 1 0.0001
724 DYSPNOEA 50 0.0001
725 IMPAIRED DRIVING ABILITY 1 0.0001
726 INTERNAL HAEMORRHAGE 1 0.0001
727 ABDOMINAL PAIN UPPER 18 0.0001
728 GASTRIC DISORDER 3 0.0001
729 MEMORY IMPAIRMENT 12 0.0001
730 TINNITUS 4 0.0001
731 DIARRHOEA 56 0.0001
732 OROPHARYNGEAL PAIN 8 0.0001
733 EYELID OEDEMA 1 0.0001
734 CAESAREAN SECTION 1 0.0001
735 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
736 COGNITIVE DISORDER 4 0.0001
737 HYPERKALAEMIA 3 0.0001
738 INJURY 6 0.0001
739 BONE PAIN 5 0.0001
740 HYPOXIA 3 0.0001
741 HYPERTENSION 18 0.0001
742 WHEEZING 5 0.0001
743 DYSPHAGIA 8 0.0001
744 BLOOD IRON DECREASED 1 0.0001
745 BACTERAEMIA 1 0.0001
746 CHOLECYSTITIS 1 0.0001
747 GAIT DISTURBANCE 16 0.0001
748 NO ADVERSE EVENT 15 0.0001
749 MENTAL IMPAIRMENT 2 0.0001
750 EXPOSURE DURING PREGNANCY 5 0.0001
751 PNEUMONIA ASPIRATION 2 0.0001
752 AGGRESSION 4 0.0001
753 DYSPNOEA EXERTIONAL 3 0.0001
754 DERMATITIS ALLERGIC 1 0.0001
755 BRAIN OEDEMA 1 0.0001
756 ACNE 6 0.0001
757 CHEST DISCOMFORT 8 0.0001
758 GENITAL HAEMORRHAGE 1 0.0001
759 ABDOMINAL PAIN 18 0.0001
760 INJECTION SITE INDURATION 1 0.0001
761 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
762 DIPLOPIA 2 0.0001
763 DEAFNESS 2 0.0001
764 WEIGHT INCREASED 17 0.0001
765 EAR INFECTION 2 0.0001
766 INSOMNIA 20 0.0001
767 CARDIAC FAILURE 6 0.0001
768 CARDIAC FAILURE CONGESTIVE 6 0.0001
769 OEDEMA 4 0.0001
770 NEUROPATHY PERIPHERAL 7 0.0001
771 PALLOR 2 0.0001
772 CONSTIPATION 16 0.0001
773 HUNGER 1 0.0001
774 INFLUENZA 8 0.0001
775 APHONIA 1 0.0001
776 PANCYTOPENIA 4 0.0001
777 DEMENTIA 2 0.0001
778 BLINDNESS UNILATERAL 1 0.0001
779 ASTHMA 8 0.0001
780 SYNCOPE 7 0.0001
781 HYPOTENSION 14 0.0001
782 CARDIOGENIC SHOCK 1 0.0001
783 MOBILITY DECREASED 5 0.0001
784 FATIGUE 54 0.0001
785 HYPOKINESIA 1 0.0001
786 PALPITATIONS 8 0.0001
787 CHILLS 8 0.0001
788 HAEMOGLOBIN DECREASED 7 0.0001
789 ANGIOEDEMA 3 0.0001
790 PSYCHOTIC DISORDER 2 0.0001
791 URINARY INCONTINENCE 2 0.0001
792 DEHYDRATION 9 0.0001
793 COLON CANCER 1 0.0001
794 IMMUNODEFICIENCY 1 0.0001
795 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
796 LACRIMATION INCREASED 2 0.0001
797 MALAISE 29 0.0001
798 DRUG DISPENSING ERROR 1 0.0001
799 EPILEPSY 2 0.0001
800 BLOOD PRESSURE INCREASED 10 0.0001
801 INJECTION SITE RASH 2 0.0001
802 HYPOKALAEMIA 3 0.0001
803 DECREASED APPETITE 15 0.0001
804 DELUSION 1 0.0001
805 SWOLLEN TONGUE 2 0.0001
806 ASTHENIA 24 0.0001
807 PYREXIA 22 0.0001
808 ARRHYTHMIA 3 0.0001
809 PULMONARY EMBOLISM 6 0.0001
810 SEPSIS 7 0.0001
811 MOOD SWINGS 2 0.0001
812 DRUG DEPENDENCE 10 0.0001
813 NIGHT SWEATS 2 0.0001
814 HYPOGLYCAEMIA 3 0.0001
815 AMNESIA 4 0.0001
816 BLOOD CREATININE INCREASED 4 0.0001
817 LUNG DISORDER 3 0.0001
818 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
819 DRUG LEVEL INCREASED 1 0.0001
820 DRY EYE 3 0.0001
821 VIRAL INFECTION 2 0.0001
822 COAGULOPATHY 1 0.0001
823 FUNGAL INFECTION 2 0.0001
824 COMPLETED SUICIDE 5 0.0001
825 URINARY RETENTION 2 0.0001
826 INJECTION SITE PRURITUS 4 0.0001
827 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
828 HAEMATURIA 2 0.0001
829 INFLAMMATION 3 0.0001
830 BALANCE DISORDER 5 0.0001
831 HAEMORRHAGE 6 0.0001
832 AMENORRHOEA 1 0.0001
833 DRUG WITHDRAWAL SYNDROME 5 0.0001
834 PANCREATITIS 3 0.0001
835 DRUG INTERACTION 9 0.0001
836 VISUAL IMPAIRMENT 7 0.0001
837 GALLBLADDER DISORDER 1 0.0001
838 GOUT 1 0.0001
839 DRUG EFFECT DECREASED 3 0.0001
840 CONFUSIONAL STATE 9 0.0001
841 ADVERSE DRUG REACTION 5 0.0001
842 COMPLICATION OF DEVICE REMOVAL 1 0.0001
843 ARTHRALGIA 23 0.0001
844 C-REACTIVE PROTEIN INCREASED 2 0.0001
845 HYPERGLYCAEMIA 2 0.0001
846 PANIC ATTACK 2 0.0001
847 RESPIRATORY FAILURE 4 0.0001
848 LOSS OF CONSCIOUSNESS 7 0.0001
849 MUSCLE SPASMS 10 0.0001
850 DRUG DOSE OMISSION 9 0.0001
851 FALL 18 0.0001
852 CHEST PAIN 10 0.0001
853 BACTERIAL INFECTION 1 0.0001
854 COUGH 15 0.0001
855 TOXICITY TO VARIOUS AGENTS 9 0.0001
856 HEPATIC CIRRHOSIS 1 0.0001
857 FRACTURE 1 0.0001
858 BLOOD URINE PRESENT 1 0.0001
859 FEELING JITTERY 1 0.0001
860 DIABETES MELLITUS 4 0.0001
861 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
862 ACUTE RESPIRATORY FAILURE 1 0.0001
863 MYOCARDIAL INFARCTION 9 0.0001
864 DYSTONIA 1 0.0001
865 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
866 PLASMA CELL MYELOMA 2 0.0001
867 KIDNEY INFECTION 1 0.0001
868 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
869 DISORIENTATION 2 0.0001
870 CATARACT 3 0.0001
871 BLOOD PRESSURE ABNORMAL 1 0.0001
872 ABORTION SPONTANEOUS 2 0.0000
873 SOMNOLENCE 10 0.0000
874 STOMATITIS 3 0.0000
875 EXTRA DOSE ADMINISTERED 2 0.0000
876 FEELING HOT 3 0.0000
877 INFLUENZA LIKE ILLNESS 4 0.0000
878 POLLAKIURIA 2 0.0000
879 PRODUCT USE ISSUE 9 0.0000
880 CARDIO-RESPIRATORY ARREST 2 0.0000
881 KNEE ARTHROPLASTY 1 0.0000
882 HALLUCINATION, VISUAL 1 0.0000
883 IRRITABLE BOWEL SYNDROME 1 0.0000
884 HYPERHIDROSIS 6 0.0000
885 HYPOACUSIS 2 0.0000
886 DEEP VEIN THROMBOSIS 3 0.0000
887 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
888 SEPTIC SHOCK 2 0.0000
889 TACHYCARDIA 4 0.0000
890 NEOPLASM MALIGNANT 3 0.0000
891 MUSCULAR WEAKNESS 5 0.0000
892 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
893 NEPHROLITHIASIS 2 0.0000
894 WEIGHT DECREASED 12 0.0000
895 PRODUCTIVE COUGH 2 0.0000
896 BLOOD PRESSURE FLUCTUATION 1 0.0000
897 CEREBROVASCULAR ACCIDENT 7 0.0000
898 ATRIAL FIBRILLATION 4 0.0000
899 AGITATION 3 0.0000
900 INJECTION SITE URTICARIA 1 0.0000
901 ABASIA 1 0.0000
902 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
903 AGEUSIA 1 0.0000
904 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
905 ABDOMINAL PAIN LOWER 1 0.0000
906 HAEMATEMESIS 1 0.0000
907 FLUID RETENTION 2 0.0000
908 HYPOPHAGIA 1 0.0000
909 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
910 NASOPHARYNGITIS 7 0.0000
911 DISTURBANCE IN ATTENTION 2 0.0000
912 PNEUMONIA 12 0.0000
913 BLOOD BILIRUBIN INCREASED 1 0.0000
914 ABNORMAL DREAMS 1 0.0000
915 DRUG ABUSE 3 0.0000
916 ARTHROPATHY 2 0.0000
917 HYPONATRAEMIA 2 0.0000
918 INTENTIONAL DOSE OMISSION 1 0.0000
919 HYPERSOMNIA 1 0.0000
920 LETHARGY 2 0.0000
921 PRODUCT SUBSTITUTION ISSUE 2 0.0000
922 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
923 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
924 DYSPHONIA 2 0.0000
925 PRODUCT DOSE OMISSION ISSUE 10 0.0000
926 IRRITABILITY 2 0.0000
927 BLOOD POTASSIUM DECREASED 1 0.0000
928 APHASIA 1 0.0000
929 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
930 SUICIDE ATTEMPT 2 0.0000
931 ILL-DEFINED DISORDER 2 0.0000
932 INJECTION SITE PAIN 10 0.0000
933 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
934 ADVERSE EVENT 3 0.0000
935 DEATH 28 0.0000
936 INJECTION SITE ERYTHEMA 4 0.0000
937 DRUG-INDUCED LIVER INJURY 1 0.0000
938 HIP FRACTURE 1 0.0000
939 DEVICE EXPULSION 2 0.0000
940 DEVICE DIFFICULT TO USE 2 0.0000
941 FEBRILE NEUTROPENIA 2 0.0000
942 BLOOD PRESSURE DECREASED 2 0.0000
943 PRODUCT QUALITY ISSUE 4 0.0000
944 HEPATIC ENZYME INCREASED 2 0.0000
945 INJECTION SITE REACTION 2 0.0000
946 DELIRIUM 1 0.0000
947 COVID-19 5 0.0000
948 HEART RATE DECREASED 1 0.0000
949 THERAPY INTERRUPTED 2 0.0000
950 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
951 DRUG EFFECT INCOMPLETE 1 0.0000
952 UNDERDOSE 2 0.0000
953 DYSGEUSIA 2 0.0000
954 THROMBOCYTOPENIA 3 0.0000
955 DYSARTHRIA 1 0.0000
956 HOT FLUSH 2 0.0000
957 BLOOD GLUCOSE INCREASED 5 0.0000
958 RHEUMATOID ARTHRITIS 3 0.0000
959 INCORRECT DOSE ADMINISTERED 6 0.0000
960 HOSPITALISATION 4 0.0000
961 PERIPHERAL SWELLING 4 0.0000
962 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
963 INJECTION SITE BRUISING 2 0.0000
964 DEVICE BREAKAGE 1 0.0000
965 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
966 BLINDNESS 1 0.0000
967 CARDIAC ARREST 2 0.0000
968 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
969 DEVICE DISLOCATION 1 0.0000
970 PRODUCT STORAGE ERROR 2 0.0000
971 BREAST CANCER 2 0.0000
972 CARDIAC DISORDER 2 0.0000
973 COMA 1 0.0000
974 ANAEMIA 4 0.0000
975 ABDOMINAL DISTENSION 2 0.0000
976 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
977 PLATELET COUNT DECREASED 2 0.0000
978 DEPENDENCE 1 0.0000
979 HAEMATOCHEZIA 1 0.0000
980 HERPES ZOSTER 1 0.0000
981 DISEASE PROGRESSION 2 0.0000
982 INTENTIONAL OVERDOSE 1 0.0000
983 NEUTROPENIA 2 0.0000
984 DEVICE MALFUNCTION 1 0.0000
985 INJECTION SITE SWELLING 1 0.0000
986 DRUG DOSE OMISSION BY DEVICE 1 0.0000
987 DRY MOUTH 1 0.0000
988 DEVICE ISSUE 1 0.0000
989 DRUG INTOLERANCE 1 0.0000